A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Virology

• Publication date

  1997-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.71.5.3834-3839.1997PMID 9094659PMCID PMC191534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid, high-level transient expression of papillomavirus-like particles in insect cells.

  1996cited by this paper
• Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.

  1996influential reference
• In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype

  1996cited by this paper
• Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein.

  1996cited by this paper
• Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus

  1996cited by this paper
• Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11

  1996cited by this paper
• Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.

  1996cited by this paper
• Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization

  1996cited by this paper
• Papillomavirus vaccines: current status and future prospects.

  1996cited by this paper
• Variability and phylogeny of the L1 capsid protein gene of human papillomavirus type 5: contribution of clusters of nonsynonymous mutations and of a 30-nucleotide duplication.

  1996cited by this paper
• Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin

  1996cited by this paper
• Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å

  1996cited by this paper
• Papillomavirus capsid binding and uptake by cells from different tissues and species

  1995cited by this paper
• Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection

  1995cited by this paper
• Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.

  1995cited by this paper
• Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells

  1995cited by this paper
• A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response

  1995cited by this paper
• Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.

  1995cited by this paper
• Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation.

  1995cited by this paper
• Update on the neutralisation of animal viruses

  1995cited by this paper
• Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins

  1994cited by this paper
• Virus receptors: binding, adhesion strengthening, and changes in viral structure

  1994cited by this paper
• Interaction of papillomaviruses with the cell surface

  1994cited by this paper
• Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles

  1993cited by this paper
• Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins

  1993cited by this paper
• Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles

  1993cited by this paper
• Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

  1992cited by this paper
• Epitope mapping.

  1992cited by this paper
• Vaccination against papillomavirus.

  1991cited by this paper
• Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins.

  1991cited by this paper
• Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

  1991cited by this paper
• Epitope mapping.

  1991cited by this paper
• Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions.

  1991cited by this paper
• Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types

  1990cited by this paper
• Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination

  1990cited by this paper
• Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

  1990cited by this paper
• Knowledge-based prediction of protein structures and the design of novel molecules

  1987cited by this paper
• The nucleotide sequence and genome organization of human papilloma virus type 11.

  1986cited by this paper
• Continuous and discontinuous protein antigenic determinants

  1986cited by this paper
• Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata

  1985cited by this paper
• Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma

  1982cited by this paper

• Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites

  2025cites this paper
• A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26.

  2022cites this paper
• Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies

  2022cites this paper
• Differential Antibody Response against Conformational and Linear Epitopes of the L1 Proteins from Human Papillomavirus Types 16/18 Is Observed in Vaccinated Women or with Uterine Cervical Lesions

  2021cites this paper
• Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus

  2017cites this paper
• Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58

  2016cites this paper
• Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus

  2016cites this paper
• Nucleotide and phylogenetic analysis of human papillomavirus type 11 isolated from juvenile‐onset recurrent respiratory papillomatosis in China

  2016cites this paper
• Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins

  2015cites this paper
• Running title : Fab induces conformational changes to HPV 16 capsids 4 5

  2014cites this paper
• Disordered interactome of human papillomavirus.

  2014cites this paper
• Regulation of gene expression in the immune system and in virally-transformed cells

  2014cites this paper
• A Cryo-Electron Microscopy Study Identifies the Complete H16.V5 Epitope and Reveals Global Conformational Changes Initiated by Binding of the Neutralizing Antibody Fragment

  2014cites this paper
• Analysis of Human Papillomavirus Capsid Proteins: Insights into Capsid Assembly

  2013influential citation
• Plant Production of Vaccine Against HPV: A New Perspectives

  2012cites this paper
• Prevaccination genomic diversity of human papillomavirus genotype 11: A study on 63 clinical isolates and 10 full‐length genome sequences

  2011cites this paper
• Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.

  2010cites this paper
• Structure, attachment and entry of polyoma- and papillomaviruses.

  2009cites this paper
• Identification of B-Cell Epitopes on Virus-Like Particles of Cutaneous Alpha-Human Papillomaviruses

  2009cites this paper
• Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications

  2009cites this paper
• Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus

  2009cites this paper
• Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.

  2008cites this paper
• Evolutionary and structural analyses of alpha-papillomavirus capsid proteins yields novel insights into L2 structure and interaction with L1

  2008cites this paper
• Cutaneous Human Papillomaviruses

  2007cites this paper
• The Humoral Immune Response to Human Papillomavirus

  2007cites this paper
• Crystal Structures of Four Types of Human Papillomavirus L1 Capsid Proteins

  2007cites this paper
• Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.

  2007cites this paper
• Characterization of B-Cells Epitopes on HPV Capsid Proteins

  2007cites this paper
• Les vaccins contre les papillomavirus

  2006cites this paper
• Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33

  2006cites this paper
• Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes

  2006cites this paper
• Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31

  2006cites this paper
• Identification of Human Papillomavirus Type 16 L1 Surface Loops Required for Neutralization by Human Sera

  2006influential citation
• Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers

  2005cites this paper
• Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type‐specific neutralizing antibodies and cross‐reactive antibodies

  2005cites this paper
• Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope

  2004cites this paper
• Induction of Mucosal and Systemic Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) by Oral Immunization with Bovine Papillomavirus-HIV-1 gp41 Chimeric Virus-Like Particles

  2004cites this paper
• Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope.

  2003cites this paper
• Different Heparan Sulfate Proteoglycans Serve asCellular Receptors for HumanPapillomaviruses

  2003cites this paper
• Human papillomavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes.

  2003cites this paper
• Identification of a Human Papillomavirus Type 16-Specific Epitope on the C-Terminal Arm of the Major Capsid Protein L1

  2003cites this paper
• Identification of a Human Papillomavirus Type 16-Specific Epitope on the C-Terminal Arm of the Major Capsid Protein L 1

  2003cites this paper
• Protective Immunity to Rabbit Oral and Cutaneous Papillomaviruses by Immunization with Short Peptides of L2, the Minor Capsid Protein

  2002cites this paper
• Identification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses

  2002cites this paper
• Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.

  2001cites this paper
• Immunological analyses of human papillomavirus capsids.

  2001cites this paper
• A novel human papillomavirus type 6 neutralizing domain comprising two discrete regions of the major capsid protein L1.

  2001cites this paper
• Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops.

  2001cites this paper
• Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

  2000cites this paper
• HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.

  2000cites this paper
• Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles.

  1999cites this paper
• Quantitative Disassembly and Reassembly of Human Papillomavirus Type 11 Viruslike Particles In Vitro

  1998cites this paper